Why Bluebird Bio Stock Is Sinking This Week

Motley Fool2022-01-14

What happenedShares of gene therapy company Bluebird Bio fell by 10.7% through the first four full days of trading this week, according to data provided by S&P Global Market Intelligence. Bluebird's ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

chqngchang
2022-01-14
chqngchang
[Smile]
FunnyFun
2022-01-14
FunnyFun
LIKE
Huimin11
2022-01-14
Huimin11
[Cool]
Hodl
2022-01-14
Hodl
[Surprised]
pet
2022-01-14
pet
Pls like

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2203371205?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2022-01-14 22:02","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2203371205","market":"us","top_or_hot":-1,"title":"Why Bluebird Bio Stock Is Sinking This Week","media":"Motley Fool","content":"<div>\n<p>What happenedShares of gene therapy company Bluebird Bio  fell by 10.7% through the first four full days of trading this week, according to data provided by S&P Global Market Intelligence. Bluebird's ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/01/14/why-bluebird-bio-stock-is-sinking-this-week/\">Source Link</a>\n\n</div>\n","source":"fool_stock","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Bluebird Bio Stock Is Sinking This Week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Bluebird Bio Stock Is Sinking This Week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-14 22:02 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/01/14/why-bluebird-bio-stock-is-sinking-this-week/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>What happenedShares of gene therapy company Bluebird Bio  fell by 10.7% through the first four full days of trading this week, according to data provided by S&P Global Market Intelligence. Bluebird's ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/01/14/why-bluebird-bio-stock-is-sinking-this-week/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BLUE","symbol_name":"bluebird bio Inc.","start_time":0,"source_url":"https://www.fool.com/investing/2022/01/14/why-bluebird-bio-stock-is-sinking-this-week/","article_id":"2203371205","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2203371205","pubTimestamp":1642168930,"sourceInfo":{"source_id":"fool_stock","name":"Motley Fool"},"weMediaInfo":null,"summary":"The biotech's latest corporate update wasn't well received by investors this week.","collect":0,"end_time":0,"defaultTopTitle":"fool.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"BLUE":"bluebird bio Inc.","BK4139":"生物科技","BK4556":"基因编辑"},"translate_title":"为什么蓝鸟生物的股票本周会下跌","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BLUE":1},"content_text":"What happenedShares of gene therapy company Bluebird Bio  fell by 10.7% through the first four full days of trading this week, according to data provided by S&P Global Market Intelligence. Bluebird's shares hit the skids last Tuesday immediately after the company provided a corporate update ahead of its presentation at the 40th Annual J.P. Morgan Health Care Conference.The key issue concerning investors appears to be the biotech's financial health. With two potential regulatory approvals and commercial launches coming down the pike later this year, Bluebird's most recent cash, cash equivalents, and marketable securities balance of approximately $442 million probably won't be sufficient to meet its short-term financial needs.So whatOn a positive note, Bluebird said it plans on exploring the sale for the priority review vouchers expected to be issued with the U.S. approvals of its gene therapies known as beti-cel and eli-cel, respectively. A sale ought to bring in approximately $150 million to $200 million in non-dilutive funding before the end of the year, according to management. The big deal is that these additional funds should extend Bluebird's cash runway into 2023.Now whatIs Bluebird's stock worth picking up on this latest weakness? Although the biotech stands a decent shot at garnering regulatory approvals for both beti-cel and eli-cel later this year, these novel gene therapies might take a few years to gain traction in the marketplace. These are groundbreaking therapies that will come with unique logistical hurdles, after all. In short, it might be best to take a wait-and-see approach with this top gene therapy stock for now.","kind":null,"is_publish_news":true,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":9005334895,"gmtCreate":1642171002305,"gmtModify":1676533688796,"author":{"id":"3582358454168309","authorId":"3582358454168309","name":"chqngchang","avatar":"https://static.tigerbbs.com/b56233832049ceeac966ba711e0e1f75","vip":1,"crmLevel":3,"crmLevelSwitch":0,"idStr":"3582358454168309","authorIdStr":"3582358454168309"},"htmlText":"[Smile]&nbsp;","listText":"[Smile]&nbsp;","text":"[Smile]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9005334895","repostId":2203371205,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9005330609,"gmtCreate":1642169743312,"gmtModify":1676533688610,"author":{"id":"3581664026895626","authorId":"3581664026895626","name":"FunnyFun","avatar":"https://static.tigerbbs.com/e07aca58746125ec6ef6115042d363e9","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3581664026895626","authorIdStr":"3581664026895626"},"htmlText":"LIKE","listText":"LIKE","text":"LIKE","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9005330609","repostId":2203371205,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9005397610,"gmtCreate":1642169412106,"gmtModify":1676533688595,"author":{"id":"4088163445989310","authorId":"4088163445989310","name":"Huimin11","avatar":"https://static.tigerbbs.com/16d3c092084f17b38b19e22d3db96b83","vip":1,"hat":"https://static.tigerbbs.com/b073a07f77dbe6b3bec6b12311fde6bd","crmLevel":2,"crmLevelSwitch":0,"idStr":"4088163445989310","authorIdStr":"4088163445989310"},"htmlText":"[Cool]&nbsp;","listText":"[Cool]&nbsp;","text":"[Cool]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9005397610","repostId":2203371205,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9005397946,"gmtCreate":1642169306109,"gmtModify":1676533688587,"author":{"id":"3579666066637422","authorId":"3579666066637422","name":"Hodl","avatar":"https://static.tigerbbs.com/d591a82f579d3114da9795812a4217a0","vip":1,"crmLevel":3,"crmLevelSwitch":0,"idStr":"3579666066637422","authorIdStr":"3579666066637422"},"htmlText":"[Surprised]&nbsp;","listText":"[Surprised]&nbsp;","text":"[Surprised]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9005397946","repostId":2203371205,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9005395653,"gmtCreate":1642169068569,"gmtModify":1676533688555,"author":{"id":"3574914454410809","authorId":"3574914454410809","name":"pet","avatar":"https://static.tigerbbs.com/d8bb8cf9a25355b93399ce59a269665b","vip":1,"crmLevel":6,"crmLevelSwitch":0,"idStr":"3574914454410809","authorIdStr":"3574914454410809"},"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9005395653","repostId":2203371205,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"}],"isCommentEnd":false,"newsSizeData":{"likeSize":26,"commentSize":5,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2203371205"}